Feature Channels: AIDS and HIV

Filters close
Newswise: After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign
Released: 18-May-2022 9:55 AM EDT
After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign
HIV Vaccine Trials Network

SEATTLE (May 18, 2022) – Building on momentum from the highly successful COVID-19 vaccine clinical trials, the HIV Vaccine Trials Network (HVTN) is launching a new HIV awareness campaign and unveiling a first-of-its-kind national registry that will provide updated HIV information and make it easier to learn about and participate in HIV clinical trials at HelpEndHIV.org.

Released: 9-May-2022 3:00 AM EDT
Effect of a Popular Web Drama Video Series on HIV and Other Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men in Singapore: Community-Based, Pragmatic, Randomized Controlled Trial
Journal of Medical Internet Research

Background: Gay, bisexual, and other men who have sex with men (GBMSM) are at disproportionately higher risk of acquiring HIV and other sexually transmitted infections (STI). While HIV/STI testing rates among GBMSM are increasing wor...

Newswise: New Tool Integrates Microbiome and Host Genetic Sequencing Analysis
Released: 5-May-2022 11:05 AM EDT
New Tool Integrates Microbiome and Host Genetic Sequencing Analysis
Texas Biomedical Research Institute

A new software tool makes it easier to study relationships between a host, its microbiome and pathogens like HIV or SARS-CoV-2.

Released: 3-May-2022 10:00 AM EDT
Albert Einstein College of Medicine Receives $11.3M NIH Grant to Expand the Einstein-Rockefeller-CUNY Center for AIDS Research
Albert Einstein College of Medicine

The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR) and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.

Newswise: Institute of Human Virology’s Mohammad Sajadi Elected to American Society for Clinical Investigation
Released: 25-Apr-2022 2:05 PM EDT
Institute of Human Virology’s Mohammad Sajadi Elected to American Society for Clinical Investigation
Institute of Human Virology at the University of Maryland School of Medicine

The American Society for Clinical Investigation (ASCI) elected Mohammad Sajadi, MD, Professor of Medicine in the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) as a 2022 member.

Newswise: Tip Sheet: Studies on COVID-19, TV and Toddler Diet Among Johns Hopkins Research to Be Featured at National Pediatrics Meeting
Released: 22-Apr-2022 12:05 PM EDT
Tip Sheet: Studies on COVID-19, TV and Toddler Diet Among Johns Hopkins Research to Be Featured at National Pediatrics Meeting
Johns Hopkins Medicine

What: Pediatric Academic Societies (PAS) 2022 Meeting When: April 21 to 25 Where: Colorado Convention Center (700 14th St., Denver, CO 80202)

Released: 14-Apr-2022 9:00 AM EDT
NIH Grant Awarded to Study HIV Drug-Resistant Genetic Mutations Across Africa
Institute of Human Virology at the University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV) researchers received funding from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for $2.7 million to study genetic changes in two genes from the HIV-1 virus that may make it resistant to antiretroviral therapy.

Released: 6-Apr-2022 1:30 PM EDT
Tip Sheet: Fred Hutch and Partners Complete Restructure, Zinc and the Immune System – and Using Cord Blood Transplants to Treat Leukemia and HIV
Fred Hutchinson Cancer Research Center

SEATTLE — April 6, 2022 — Below are summaries of recent Fred Hutchinson Cancer Research Center research findings and other news. If you’re covering the American Association of Cancer Research’s annual meeting, April 8-13, see our list of Fred Hutch highlights for AACR and contact for help setting up interviews with experts.

Released: 5-Apr-2022 3:55 PM EDT
The latest news on clinical trials is here on Newswise
Newswise

Here are some of the latest articles that have been added to the Clinical Trials channel on Newswise.

Newswise: CRISPR Clinical Trials: A 2022 Update
Released: 30-Mar-2022 2:35 PM EDT
CRISPR Clinical Trials: A 2022 Update
Innovative Genomics Institute

A comprehensive look at all of the active clinical trials on new CRISPR-based genome editing therapies in 2022, and perspective on what is coming next.

Released: 25-Mar-2022 11:40 AM EDT
Study Examines Racial Disparities Among Women with Syphilis
University at Albany, State University of New York

As syphilis cases continue to rise across the United States, a new analysis from researchers at the Coalition for Applied Modeling for Prevention (CAMP) offers further insight into racial and ethnic disparities in syphilis rates among heterosexually active women, featuring a new approach to analyzing disease impact.

Newswise: UCLA’s HIV prevention and treatment center receives $7.5 million grant from NIH
Released: 17-Mar-2022 5:15 PM EDT
UCLA’s HIV prevention and treatment center receives $7.5 million grant from NIH
University of California, Los Angeles (UCLA), Health Sciences

The National Institute of Mental Health has renewed its support for UCLA’s collaborative Center for HIV Identification, Prevention and Treatment Services, or CHIPTS, with a five-year, $7.5 million grant.

Released: 15-Mar-2022 7:05 PM EDT
Increased support needed for a coordinated global HIV and COVID-19 response
HIV Vaccine Trials Network

In a JAMA perspective piece, leading infectious disease researchers call for a coordinated response to HIV and COVID-19 globally, building on the successes of key donor programs such as the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program and Global Fund to Fight AIDS, TB and Malaria (GFATM).

Released: 15-Mar-2022 11:05 AM EDT
Study Shows mRNA Vaccine Technology Can Be Used For HIV Vaccines
Duke Health

Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.

Released: 14-Mar-2022 9:00 AM EDT
Trial of innovative HIV vaccine using mRNA technology enrolls first participant
HIV Vaccine Trials Network

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna. The study evaluates the safety of and immune responses to three different experimental vaccines against HIV. This randomized, open-label trial represents one of the first clinical studies of the use of mRNA vaccine technology against HIV.

Released: 8-Mar-2022 11:40 AM EST
Understanding modern infectious diseases and their impacts
International Institute for Applied Systems Analysis (IIASA)

A new study set out to better understand the impacts and trade-offs policymakers must consider when addressing modern infectious diseases and their macroeconomic repercussions.

Released: 8-Mar-2022 9:00 AM EST
Global Virus Network Announces Inaugural Participants of Postdoctoral Fellowship Program
Global Virus Network

The three awardees will receive training and mentorship to help support and propel their rising careers in virology

Newswise: New UCI study finds Harnessing Online Peer Education to be an effective tool for HIV prevention
Released: 28-Feb-2022 3:00 PM EST
New UCI study finds Harnessing Online Peer Education to be an effective tool for HIV prevention
University of California, Irvine

A new University of California, Irvine-led study, called the HOPE (Harnessing Online Peer Education) HIV study, revealed that using peer-led online communities was successful in increasing HIV self-testing and reducing alcohol consumption among Latinx and African American MSM (men who have sex with men).

Released: 22-Feb-2022 4:50 PM EST
COVID-19 genetic risk variant protects against HIV
Max Planck Institute for Evolutionary Anthropology

Some people become seriously ill when infected with SARS-CoV-2 while others have only mild symptoms or no symptoms at all.

Released: 16-Feb-2022 3:05 PM EST
Unexpected findings detailed in new portrait of HIV
University of Washington

Using powerful tools and techniques developed in the field of structural biology, researchers at the University of Washington and The Scripps Research Institute have discovered new details about the human immunodeficiency virus, HIV.

Newswise: Starting antiretroviral therapy early essential to battling not one, but two killers
Released: 15-Feb-2022 4:05 PM EST
Starting antiretroviral therapy early essential to battling not one, but two killers
Texas Biomedical Research Institute

Medication against the nonhuman primate version of HIV given two weeks after infection helped keep tuberculosis in check.

Released: 11-Feb-2022 1:45 PM EST
HIV Incidence Rising Steeply Among People Who Inject Drugs in Tijuana
University of California San Diego Health

Researchers at UC San Diego School of Medicine have presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by “drug tourism” unabated by the closure of the international border due to the COVID-19 pandemic.

Newswise: UCLA Fielding School of Public Health Announces The 47th Lester Breslow Distinguished Lecture
Released: 8-Feb-2022 12:25 PM EST
UCLA Fielding School of Public Health Announces The 47th Lester Breslow Distinguished Lecture "Recognizing Opportunities"
UCLA Fielding School of Public Health

Join the UCLA Fielding School of Public for the 47th Lester Breslow Distinguished Lecture. Dr. Roger Detels — distinguished research professor of epidemiology at the UCLA Fielding School of Public Health and infectious diseases at the David Geffen School of Medicine at UCLA — will present opportunities realized that have contributed to advancing our understanding of disease pathogenesis as well as the shaping of public health policy and promoting of future public health leaders, both nationally and internationally. The event will be hosted by Dr. Ron Brookmeyer, dean of the UCLA Fielding School of Public Health.

Released: 8-Feb-2022 9:00 AM EST
Global Virus Network (GVN) Adds the Centre for the AIDS Programme of Research in South Africa (CAPRISA) as Newest Member to Combat Viral Threats
Global Virus Network

Baltimore, Maryland, USA, February 8, 2021: The Global Virus Network (GVN), representing 68 Centers of Excellence and 10 Affiliates in 36 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre for the AIDS Programme of Research in South Africa (CAPRISA) in Durban announced the addition of CAPRISA as GVN’s newest Center of Excellence.

Newswise: Wistar Scientists Move HIV Vaccine Research Forward by Developing an Immunogen that Produces Tier-2 Antibodies—the Kind That Matter for Combatting HIV
3-Feb-2022 3:55 PM EST
Wistar Scientists Move HIV Vaccine Research Forward by Developing an Immunogen that Produces Tier-2 Antibodies—the Kind That Matter for Combatting HIV
Wistar Institute

Wistar Institute scientists take a promising step in the direction of developing an HIV vaccine that uses a unique native-like trimer to develop Tier-2 neutralizing antibodies—the kind that matter for combatting HIV—in mice for the first time.

Newswise: IU-led global health network AMPATH adds sites in Mexico, Ghana
Released: 2-Feb-2022 10:50 AM EST
IU-led global health network AMPATH adds sites in Mexico, Ghana
Indiana University

An Indiana University-led global health program developed in Kenya is expanding to improve health in new locations in Ghana and Mexico.

Released: 27-Jan-2022 6:05 PM EST
Better education needed about oral sex disease risk, poll of young people shows
Michigan Medicine - University of Michigan

Most teens and young adults know it’s possible to catch or spread a sexually transmitted infection by having unprotected oral sex, a new poll shows. But more than half underestimate the level of that risk, including many who focus on avoiding pregnancy risk, the data show.

Released: 27-Jan-2022 12:50 PM EST
Case Western Reserve dental school researcher awarded $3.7M in NIH grants to study link between people living with HIV and higher rates of cancer and other diseases
Case Western Reserve University

A Case Western Reserve dental school researcher was awarded $3.7M in NIH grants to study the link between people living with HIV and higher rates of cancer and other diseases.

Newswise: UCLA Fielding School Center for LGBTQ+ Advocacy, Research & Health Marks Its First Year
Released: 26-Jan-2022 12:25 PM EST
UCLA Fielding School Center for LGBTQ+ Advocacy, Research & Health Marks Its First Year
UCLA Fielding School of Public Health

In it’s first year, the Fielding School’s UCLA Center for LGBTQ+ Advocacy, Research & Health (C-LARAH) has had impact across a spectrum of applied research and organizational work, focused on increasing equity for an underserved community.

Newswise: Young Sexual Minority Men and Transgender Women Are at Higher Risk of Transactional Sex
Released: 25-Jan-2022 9:30 AM EST
Young Sexual Minority Men and Transgender Women Are at Higher Risk of Transactional Sex
Johns Hopkins Medicine

About a fifth of young sexual minority males and transgender females are estimated to be engaging in transactional, or survival sex, according to results of a new survey study by Johns Hopkins Medicine researchers.

Released: 24-Jan-2022 3:40 PM EST
The Latest Research News from the Health Disparities Channel
Newswise

The latest research news from the Health Disparities Channel.

Released: 21-Jan-2022 9:00 AM EST
State Laws About Prescribing May Limit Access to HIV Pre-exposure Prophylaxis
Wolters Kluwer Health: Lippincott

State laws in the US that require medical doctors (MDs) to determine which medications a nurse practitioner (NP) or physician assistant (PA) can prescribe, and under what conditions, may limit the number of patients who use HIV pre-exposure prophylaxis (PrEP), reports a study in The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Released: 21-Jan-2022 8:05 AM EST
People Living with HIV Need Tailored COVID-19 Vaccination Information
Rutgers University-New Brunswick

While most people living with HIV have received at least one dose of the COVID-19 vaccine, younger and Black individuals are hesitant to get vaccinated and have lower vaccination rates, according to a new study by Rutgers researchers.

Newswise:Video Embedded fau-lands-1-3-million-nih-grant-for-rapid-automated-hiv-self-test
VIDEO
Released: 13-Jan-2022 8:30 AM EST
FAU Lands $1.3 Million NIH Grant for Rapid, Automated HIV Self-test
Florida Atlantic University

With this NIH grant, FAU researchers are developing an affordable, disposable self-testing HIV-1 chip that can selectively detect HIV from whole blood samples, be highly sensitive to detect HIV during the acute infection, treatment and viral rebound; be rapid within 40 minutes; highly stable without requiring refrigeration; and fully automated providing true sample-in-answer-out ability.

Newswise: UCLA-led team refines ‘kick and kill’ strategy aimed at eliminating HIV-infected cells
Released: 11-Jan-2022 8:05 PM EST
UCLA-led team refines ‘kick and kill’ strategy aimed at eliminating HIV-infected cells
University of California, Los Angeles (UCLA), Health Sciences

In a study using mice, a UCLA-led team of researchers have improved upon a method they developed in 2017 that was designed to kill HIV-infected cells. The advance could move scientists a step closer to being able to reduce the amount of virus, or even eliminate it, from infected people.

Newswise: Tomato concentrate could help reduce chronic intestinal inflammation associated with HIV
Released: 11-Jan-2022 5:30 PM EST
Tomato concentrate could help reduce chronic intestinal inflammation associated with HIV
University of California, Los Angeles (UCLA), Health Sciences

New UCLA-led research in mice suggests that adding a certain type of tomato concentrate to the diet can reduce the intestinal inflammation that is associated with HIV. Left untreated, intestinal inflammation can accelerate arterial disease, which in turn can lead to heart attack and stroke.

Newswise:Video Embedded hiv-and-screening-where-do-we-go-from-here
VIDEO
Released: 29-Dec-2021 10:05 AM EST
HIV and Screening: Where Do We Go From Here?
Diseases of the Colon and Rectum Journal

The January 2022 issue of Disease of the Colon and Rectum Features an Update on People Living With HIV

Released: 17-Dec-2021 11:05 AM EST
Study shows how HIV copies itself in the body
Ohio State University

HIV replication in the human body requires that specific viral RNAs be packaged into progeny virus particles. A new study has found how a small difference in the RNA sequence can allow the viral RNA to be packaged for replication, creating potential targets for future HIV treatments.

Newswise: Bridging the health care communications gap for transgender men
Released: 16-Dec-2021 2:40 PM EST
Bridging the health care communications gap for transgender men
University of Texas Health Science Center at Houston

Transgender men face significant health and social disparities, including barriers to health care, research, and essential HIV-related conversations with their health care providers. That is why Paige Wermuth, PhD, MPH, assistant professor in the Department of Management, Policy, and Community Health, and graduate student Lou Weaver of The University of Texas Health Science Center (UTHealth Houston) School of Public Health are launching a pilot project to examine and develop communication materials for trans men and their health care providers regarding HIV prevention.

Released: 14-Dec-2021 8:05 PM EST
HVTN Faith Initiative expands to help build bridges between community and HIV vaccine trials
HIV Vaccine Trials Network

While the rapid development of effective vaccines has helped combat the COVID-19 pandemic, key communities – especially people who are living with HIV – remain disproportionately impacted, and are at higher risk of severe disease and death. Finding an effective HIV vaccine is critically important, and to that end, the HIV Vaccine Trials Network (HVTN) is launching an expanded Faith Initiative that will help advance the work of finding a cure.

Released: 14-Dec-2021 10:35 AM EST
Duke Institute Lands Federal Contract to Make Vaccine Candidates
Duke Health

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

Released: 13-Dec-2021 1:25 PM EST
Landmark COVID-19 vaccine trial in sub-Saharan Africa is the first to study the efficacy of mRNA COVID-19 vaccines in people living with HIV
Covid-19 Prevention Network (CoVPN)

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections. It also is the first study to evaluate the efficacy of vaccines – in this case, Moderna mRNA-1273 – against the omicron variant of SARS-CoV-2, the virus that causes COVID-19.

Newswise: UTEP to Work on Solutions to Reduce Drug Use-Related HIV in the El Paso-Ciudad Juárez Border
Released: 10-Dec-2021 3:00 PM EST
UTEP to Work on Solutions to Reduce Drug Use-Related HIV in the El Paso-Ciudad Juárez Border
University of Texas at El Paso

The University of Texas at El Paso will develop a sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juárez border region. The initiative will be funded by a $3 million grant from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA).

Released: 8-Dec-2021 11:05 AM EST
Racial Bias among Doctors May Exacerbate Disparities in HIV Prevention, Rutgers-led Study Finds
Rutgers University-New Brunswick

Racial bias among health care providers may limit the number of Black women who could be taking a daily pill to prevent HIV infection, according to a Rutgers-led study.

Newswise: Meth use, intimate partner violence weaken immune function in HIV-positive men
Released: 3-Dec-2021 4:05 PM EST
Meth use, intimate partner violence weaken immune function in HIV-positive men
University of California, Los Angeles (UCLA), Health Sciences

Among HIV-positive black and Latino men who have sex with men, the use of methamphetamine combined with intimate partner violence may increase the risk for developing chronic diseases such as cardiovascular disease and other disorders.


Showing results

150 of 1603

close
1.00555